PCM
LXRX icon

Piermont Capital Management’s Lexicon Pharmaceuticals LXRX Stock Holding History

Piermont Capital Management’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-14,400
Closed -$177K – 252
2017
Q3 		$177K Sell
14,400
-15,310
-52% -$226K 0.06% 241
2017
Q2 		$489K Sell
29,710
-5,160
-15% -$79.9K 0.14% 230
2017
Q1 		$500K Hold
34,870
– – 0.12% 230
2016
Q4 		$482K Sell
34,870
-670
-2% -$10.8K 0.11% 229
2016
Q3 		$642K Buy
+35,540
New +$572K 0.15% 207

Other funds holding LXRX

AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
UL
Ulys LLC New York $25.4M AUM 201.03% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UIM
USS Investment Management London, United Kingdom $25.6B AUM 30.22% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CLM
ClearBridge LLC (Maryland) Baltimore, Maryland $329M AUM 9.73% 1-Year Est. Return